Johnson Johnson Innovation Launches Reimagining Respiratory Protection QuickFire Challenge in Collaboration with the U.S. Department of Health and Human Services: Johnson & Johnson Innovation, JLABS teams with the Biomedical Advanced Research and Development Authority (BARDA) to advance new technologies to improve global pandemic preparedness against respiratory infection outbreaks
Published in PR Newswire
(30.10.2018)
Get full text
Newsletter
NewLink Genetics and Merck receive Ebola vaccine contract from US Biomedical Advanced Research and Development Authority
Published in M2 Pharma
(23.12.2014)
Get full text
Newsletter
The Biomedical Advanced Research and Development Authority extends collaboration with Pfenex
Published in M2 Pharma
(03.10.2013)
Get full text
Newsletter
The Biomedical Advanced Research and Development Authority
Published in Federal register
(14.08.2018)
Get full text
Newspaper Article
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine: Funding will be provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services
Published in PR Newswire
(01.05.2012)
Get full text
Newsletter
Cempra receives contract from Biomedical Advanced Research and Development Authority
Published in M2 Pharma
(30.05.2013)
Get full text
Newsletter
Argentum Medical Awarded $8.4M BARDA Contract for Silverlon Wound Technology to Prepare U.S. for Nuclear and Radiation Emergencies: As a pioneer of silver technology, the privately held Silverlon has been awarded a three-year, $8.4 million contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. This contract will look at the potential use of its Silverlon technology for use for low-grade and severe skin radiation injuries after a radiation emergency
Published in PR Newswire
(24.10.2018)
Get full text
Newsletter
Marinus Pharmaceuticals Announces Exercise of First Contract Option by the Biomedical Advanced Research and Development Authority (BARDA)
Published in Business Wire
(22.09.2022)
Get full text
Newspaper Article
Biomedical Advanced Research and Development Authority Exercises Option with Pfenex on Anthrax Vaccine
Published in Health & Beauty Close - Up
(04.05.2012)
Get full text
Newsletter
Biomedical Advanced Research and Development Authority Extends Contract with Pfenex
Published in Professional Services Close - Up
(04.05.2012)
Get full text
Newsletter
Pfenex Inc. Awarded HHS Contract Valued At Up To $143.5 Million For The Advanced Development Of Next Generation Anthrax Vaccine: Contract administered by the Biomedical Advanced Research and Development Authority focused on Pfenex's Px563L
Published in PR Newswire
(17.08.2015)
Get full text
Newsletter